BEVESPI AEROSPHERE

AstraZeneca Pharmaceuticals LP🇺🇸 United States

FDA Page

Effective Date: Mar 24, 2023
Approval ID: ae02436e-9528-490e-a844-0c0f6f2843f9
Products: 1 registered
Version: 23

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use BEVESPI AEROSPHERE safely and effectively. See full prescribing information for BEVESPI AEROSPHERE. BEVESPI AEROSPHERE(glycopyrrolate and formoterol fumarate) inhalation aerosol, for oral inhalation useInitial U.S. Approval: 2016

Quick Stats

Total Products1

Labelers2

Label Sections22

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.